• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
QRX
Click for more information
0.00% 2.8¢

QRXPHARMA LTD - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
QRX Removal from Official List23/05/18
QRX Appendix 4C - Quarter Ended 31 March 2018PRICE SENSITIVE20/04/18
QRX Initial Director's Interest Notice27/03/18
QRX Director Appointment23/03/18
QRX Half Yearly Report and Accounts - 31 December 2017PRICE SENSITIVE26/02/18
QRX Appendix 4C - Quarter Ended 31 December 201718/01/18
QRX Results of Meeting20/11/17
QRX Chairman's Address to Shareholders20/11/17
QRX Notice of Annual General Meeting/Proxy Form18/10/17
QRX Appendix 4C - Quarter Ended 30 September 201717/10/17
QRX Appendix 4G - Corporate Governance28/09/17
QRX Annual Report to shareholders28/09/17
QRX Preliminary Final Report30/08/17
QRX Appendix 4C - Quarter Ended 30 June 201731/07/17
QRX Appendix 4C - Quarter Ended 31 March 201711/04/17
QRX Half Yearly Report and Accounts - 31 December 201622/02/17
QRX Appendix 4C - Quarter Ended 31 December 201617/01/17
QRX Auditor Appointment / Resignation19/12/16
QRX Results of Meeting29/11/16
QRX Chairman's Address to Shareholders29/11/16
QRX Notice of Annual General Meeting/Proxy Form-QRX.AX 25/10/16
QRX Appendix 4C - Quarter Ended 30 September 2016-QRX.AX 19/10/16
QRX Initial Director's Interest Notice- J Rainbow-QRX.AX 14/10/16
QRX Initial Director's Interest Notice- T Heesh-QRX.AX 14/10/16
QRX Final Director's Interest Notice- B Hancox-QRX.AX 14/10/16
QRX Final Director's Interest Notice- R Treagus-QRX.AX 14/10/16
QRX Change in Board Composition-QRX.AX 11/10/16
QRX Change of Registered Office & Company Secretary-QRX.AX 22/08/16
QRX Appendix 4G - Corporate Governance Statement-QRX.AX 18/08/16
QRX Preliminary Final Report - 30 June 2016-QRX.AX 18/08/16
QRX Appendix 4C - Quarter Ended 30 June 2016-QRX.AX 05/08/16
QRX Change of Director's Interest Notice - Bruce Hancox-QRX.AX 26/05/16
QRX Results of 2015 Annual General Meeting-QRX.AX 19/05/16
QRX Chairman's Address to Shareholders-QRX.AX 19/05/16
QRX Appendix 4C - Quarter Ended 31 March 2016-QRX.AX 10/05/16
QRX Notice of 2015 Annual General Meeting/Proxy Form-QRX.AX 15/04/16
QRX Half Yearly Report and Accounts - 31 December 201511/03/16
QRX Appendix 4C - Quarter Ended 31 December 201509/02/16
QRX Appendix 4C - Quarter Ended 30 September 201509/02/16
QRX Appendix 4G - Corporate Governance Statement09/02/16
QRX Annual report and full year financial results - 30 June 201509/02/16
QRX Appendix 4C - Quarter Ended 30 June 201509/02/16
QRX Letter to Shareholders24/12/15
QRX Letter to Shareholders09/12/15
QRX Letter to Shareholders07/12/15
QRX Letter to Shareholders /Notice of meeting of Creditors11/11/15
QRX Letter to Shareholders26/10/15
QRX Letter to Shareholders02/10/15
QRX ASX Announcement15/09/15
QRX Letter to Shareholders07/09/15
QRX Letter to Shareholders24/06/15
QRX ASX Announcement22/06/15
QRX Response to ASX Price Query27/05/15
QRX Appointment of Voluntary Administrator22/05/15
QRX Suspension from Official QuotationPRICE SENSITIVE22/05/15
QRX Appendix 4C - Quarter Ended 31 March 2015PRICE SENSITIVE22/04/15
QRX Response to ASX Price QueryPRICE SENSITIVE02/04/15
QRX Change in substantial holding10/03/15
QRX Half Yearly Report and Accounts - 31 December 2014PRICE SENSITIVE25/02/15
QRX Appendix 4C - Quarter Ended 31 December 2014PRICE SENSITIVE27/01/15
QRX Results of 2014 Annual General Meeting29/10/14
QRX Chairman's Address to Shareholders29/10/14
QRX Appendix 4C - Quarter Ended 30 September 2014PRICE SENSITIVE24/10/14
QRX Annual Report to Shareholders - 201426/09/14
QRX Notice of 2014 Annual General Meeting and Proxy Form26/09/14
QRX 2014 Annual General Meeting - Wednesday, 29 October 201428/08/14
QRX Preliminary Final Report - 30 June 2014PRICE SENSITIVE27/08/14
QRX QRxPharma Halts Moxduo DevelopmentPRICE SENSITIVE14/08/14
QRX QRxPharma General Shareholder Update31/07/14
QRX Appendix 4C - Quarter Ended 30 June 2014PRICE SENSITIVE17/07/14
QRX Initial Director's Interest Notice - Richard Treagus14/07/14
QRX Initial Director's Interest Notice - Bruce Hancox14/07/14
QRX Final Director's Interest Notice - Peter Campbell14/07/14
QRX Final Director's Interest Notice - Michael Quinn14/07/14
QRX Final Director's Interest Notice - Gary Pace14/07/14
QRX Final Director's Interest Notice - Peter Farrell14/07/14
QRX Feedback on End-of-Review Meeting with the FDA on Moxduo11/07/14
QRX Results of 9 July 2014 General Meeting09/07/14
QRX Board Resignations and General Meeting Chairman's Address09/07/14
QRX Letter to Shareholders from Chairman of General Meeting27/06/14
QRX Change of Director's Interest Notice - Michael Quinn26/06/14
QRXFDA Confirms Review Meeting Regarding MOXDUO NDA04/06/14
QRXNotice of General Meeting/Proxy Form - 9 July 201403/06/14
QRXChange of Director's Interest Notice - Peter Campbell29/05/14
QRXChange of Director's Interest Notice - Michael Quinn29/05/14
QRXChange of Director's Interest Notice - Peter Farrell29/05/14
QRXComplete Response Letter from FDA regarding Moxduo NDAPRICE SENSITIVE26/05/14
QRXMoxduo Status Overview May 201419/05/14
QRXNotice under Sections 249D & 203D of the Corporations Act14/05/14
QRXFinal Director's Interest Notice - John Holaday07/05/14
QRXChange of Director's Interest Notice - Gary Pace07/05/14
QRXChange of Director's Interest Notice - John Holaday07/05/14
QRXAppendix 3B - Option Issue02/05/14
QRXCEO Remuneration Package and Key Terms02/05/14
QRXReissue - Dr. Edward Rudnic Appointed CEO of QRxPharma02/05/14
QRXDr. Edward Rudnic Appointed CEO of QRxPharmaPRICE SENSITIVE02/05/14
QRXAppendix 4C - Quarter Ended 31 March 2014PRICE SENSITIVE29/04/14
QRXCEO Discusses Moxduo Advisory Committee Meeting Outcomee23/04/14
QRXQRxPharma Issues Statement On Moxduo Advisory CommitteePRICE SENSITIVE23/04/14
QRXFDA Webcast Details For Moxduo Advisory Committee Meeting22/04/14
QRX Removal from Official List
23/05/18
QRX Appendix 4C - Quarter Ended 31 March 2018
20/04/18PRICE SENSITIVE
QRX Initial Director's Interest Notice
27/03/18
QRX Director Appointment
23/03/18
QRX Half Yearly Report and Accounts - 31 December 2017
26/02/18PRICE SENSITIVE
QRX Appendix 4C - Quarter Ended 31 December 2017
18/01/18
QRX Results of Meeting
20/11/17
QRX Chairman's Address to Shareholders
20/11/17
QRX Notice of Annual General Meeting/Proxy Form
18/10/17
QRX Appendix 4C - Quarter Ended 30 September 2017
17/10/17
QRX Appendix 4G - Corporate Governance
28/09/17
QRX Annual Report to shareholders
28/09/17
QRX Preliminary Final Report
30/08/17
QRX Appendix 4C - Quarter Ended 30 June 2017
31/07/17
QRX Appendix 4C - Quarter Ended 31 March 2017
11/04/17
QRX Half Yearly Report and Accounts - 31 December 2016
22/02/17
QRX Appendix 4C - Quarter Ended 31 December 2016
17/01/17
QRX Auditor Appointment / Resignation
19/12/16
QRX Results of Meeting
29/11/16
QRX Chairman's Address to Shareholders
29/11/16
QRX Notice of Annual General Meeting/Proxy Form-QRX.AX
25/10/16
QRX Appendix 4C - Quarter Ended 30 September 2016-QRX.AX
19/10/16
QRX Initial Director's Interest Notice- J Rainbow-QRX.AX
14/10/16
QRX Initial Director's Interest Notice- T Heesh-QRX.AX
14/10/16
QRX Final Director's Interest Notice- B Hancox-QRX.AX
14/10/16
QRX Final Director's Interest Notice- R Treagus-QRX.AX
14/10/16
QRX Change in Board Composition-QRX.AX
11/10/16
QRX Change of Registered Office & Company Secretary-QRX.AX
22/08/16
QRX Appendix 4G - Corporate Governance Statement-QRX.AX
18/08/16
QRX Preliminary Final Report - 30 June 2016-QRX.AX
18/08/16
QRX Appendix 4C - Quarter Ended 30 June 2016-QRX.AX
05/08/16
QRX Change of Director's Interest Notice - Bruce Hancox-QRX.AX
26/05/16
QRX Results of 2015 Annual General Meeting-QRX.AX
19/05/16
QRX Chairman's Address to Shareholders-QRX.AX
19/05/16
QRX Appendix 4C - Quarter Ended 31 March 2016-QRX.AX
10/05/16
QRX Notice of 2015 Annual General Meeting/Proxy Form-QRX.AX
15/04/16
QRX Half Yearly Report and Accounts - 31 December 2015
11/03/16
QRX Appendix 4C - Quarter Ended 31 December 2015
09/02/16
QRX Appendix 4C - Quarter Ended 30 September 2015
09/02/16
QRX Appendix 4G - Corporate Governance Statement
09/02/16
QRX Annual report and full year financial results - 30 June 2015
09/02/16
QRX Appendix 4C - Quarter Ended 30 June 2015
09/02/16
QRX Letter to Shareholders
24/12/15
QRX Letter to Shareholders
09/12/15
QRX Letter to Shareholders
07/12/15
QRX Letter to Shareholders /Notice of meeting of Creditors
11/11/15
QRX Letter to Shareholders
26/10/15
QRX Letter to Shareholders
02/10/15
QRX ASX Announcement
15/09/15
QRX Letter to Shareholders
07/09/15
QRX Letter to Shareholders
24/06/15
QRX ASX Announcement
22/06/15
QRX Response to ASX Price Query
27/05/15
QRX Appointment of Voluntary Administrator
22/05/15
QRX Suspension from Official Quotation
22/05/15PRICE SENSITIVE
QRX Appendix 4C - Quarter Ended 31 March 2015
22/04/15PRICE SENSITIVE
QRX Response to ASX Price Query
02/04/15PRICE SENSITIVE
QRX Change in substantial holding
10/03/15
QRX Half Yearly Report and Accounts - 31 December 2014
25/02/15PRICE SENSITIVE
QRX Appendix 4C - Quarter Ended 31 December 2014
27/01/15PRICE SENSITIVE
QRX Results of 2014 Annual General Meeting
29/10/14
QRX Chairman's Address to Shareholders
29/10/14
QRX Appendix 4C - Quarter Ended 30 September 2014
24/10/14PRICE SENSITIVE
QRX Annual Report to Shareholders - 2014
26/09/14
QRX Notice of 2014 Annual General Meeting and Proxy Form
26/09/14
QRX 2014 Annual General Meeting - Wednesday, 29 October 2014
28/08/14
QRX Preliminary Final Report - 30 June 2014
27/08/14PRICE SENSITIVE
QRX QRxPharma Halts Moxduo Development
14/08/14PRICE SENSITIVE
QRX QRxPharma General Shareholder Update
31/07/14
QRX Appendix 4C - Quarter Ended 30 June 2014
17/07/14PRICE SENSITIVE
QRX Initial Director's Interest Notice - Richard Treagus
14/07/14
QRX Initial Director's Interest Notice - Bruce Hancox
14/07/14
QRX Final Director's Interest Notice - Peter Campbell
14/07/14
QRX Final Director's Interest Notice - Michael Quinn
14/07/14
QRX Final Director's Interest Notice - Gary Pace
14/07/14
QRX Final Director's Interest Notice - Peter Farrell
14/07/14
QRX Feedback on End-of-Review Meeting with the FDA on Moxduo
11/07/14
QRX Results of 9 July 2014 General Meeting
09/07/14
QRX Board Resignations and General Meeting Chairman's Address
09/07/14
QRX Letter to Shareholders from Chairman of General Meeting
27/06/14
QRX Change of Director's Interest Notice - Michael Quinn
26/06/14
QRXFDA Confirms Review Meeting Regarding MOXDUO NDA
04/06/14
QRXNotice of General Meeting/Proxy Form - 9 July 2014
03/06/14
QRXChange of Director's Interest Notice - Peter Campbell
29/05/14
QRXChange of Director's Interest Notice - Michael Quinn
29/05/14
QRXChange of Director's Interest Notice - Peter Farrell
29/05/14
QRXComplete Response Letter from FDA regarding Moxduo NDA
26/05/14PRICE SENSITIVE
QRXMoxduo Status Overview May 2014
19/05/14
QRXNotice under Sections 249D & 203D of the Corporations Act
14/05/14
QRXFinal Director's Interest Notice - John Holaday
07/05/14
QRXChange of Director's Interest Notice - Gary Pace
07/05/14
QRXChange of Director's Interest Notice - John Holaday
07/05/14
QRXAppendix 3B - Option Issue
02/05/14
QRXCEO Remuneration Package and Key Terms
02/05/14
QRXReissue - Dr. Edward Rudnic Appointed CEO of QRxPharma
02/05/14
QRXDr. Edward Rudnic Appointed CEO of QRxPharma
02/05/14PRICE SENSITIVE
QRXAppendix 4C - Quarter Ended 31 March 2014
29/04/14PRICE SENSITIVE
QRXCEO Discusses Moxduo Advisory Committee Meeting Outcomee
23/04/14
QRXQRxPharma Issues Statement On Moxduo Advisory Committee
23/04/14PRICE SENSITIVE
QRXFDA Webcast Details For Moxduo Advisory Committee Meeting
22/04/14
refresh Created with Sketch. REFRESH
 

Top Stories

Sales growth pushes Lovisa's fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.